Clinical Trials Logo

Clinical Trial Summary

As a medium-and long-term non-depolarizing muscle relaxant, rocuronium has the advantages of quick effect, no histamine release and accumulation and no obvious cardiovascular adverse reactions, so it has been widely used in clinical anesthesia induction. However, when given intravenously, rocuronium can cause adverse reactions such as injection pain and limb retraction, which can lead to needle prolapse, extravasation of injection drugs, swelling of injection site, serious induction delay, and cardiovascular adverse events in severe cases. Remifentanil is a synthetic opioid drug hydrolyzed by esterase. Compared with other opioid drugs, remifentanil has the advantages of quick effect, short half-life and short time of hemodynamic changes, so it is an ideal analgesic in clinical anesthesia. In this study, in order to provide clinical references, sequential method was used to find the median effective dose (ED50) by means of pre-intravenous injection of Remifentanil to suppress pain in rocuronium injection.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05217238
Study type Interventional
Source Yangzhou University
Contact
Status Recruiting
Phase N/A
Start date December 18, 2021
Completion date March 30, 2022

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05515835 - Relationship Between Effect Duration of Rocuronium and Body Composition Analysis Data.
Completed NCT01672606 - Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea N/A
Completed NCT05066035 - Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine Phase 4
Completed NCT05343702 - Comparison of Standard rapi̇d Sequential Intubation Protocol With Rocuronium in Emergency Department
Not yet recruiting NCT05067829 - Rapid Sequence Intubation With Rocuronium in Elderly Patients N/A
Recruiting NCT05028088 - Diaphragm Ultrasound to Evaluate the Antagonistic Effect of Sugammadex Phase 4
Completed NCT05476952 - Lean Body Weight-adjusted Rocuronium Dose and Intubation Conditions
Recruiting NCT04124757 - Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety N/A
Recruiting NCT02989272 - Effect of Pre-treatment With Magnesium Sulfate on the Duration of Deep Neuromuscular Blockade With Rocuronium Phase 4
Completed NCT04236050 - Continuous Infusion and Bolus Doses of Rocuronium During Lumbal Discectomy, Muscle Strength and Patient Recovery N/A
Recruiting NCT04821817 - Peribulbar Rocuronium in Adult Strabismus Surgery N/A
Enrolling by invitation NCT04760912 - General Anesthesia With and Without Muscle Relaxation and Muscle Strength Recovery N/A